L-arginine transport in humans with cortisol-induced hypertension

Hypertension

Volumn 41, Issue 6, 2003, Pages 1336-1340

  Chin Dusting, Jaye P F ^a,d   Ahlers, Belinda A ^a   Kaye, David M ^a   Kelly, John J ^b   Whitworth, Judith A ^c  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Biology and Environment   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Arginine; Cortisol; Human; Hypertension, mineralocorticoid; Nitric oxide

Indexed keywords

ARGININE; HYDROCORTISONE; NITRIC OXIDE;

ADULT; AMINO ACID TRANSPORT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CHOLINERGIC ACTIVITY; FOREARM BLOOD FLOW; HEART OUTPUT; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPERTENSION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; SYMPATHETIC TONE;

ADULT; ARGININE; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; BRACHIAL ARTERY; FOREARM; HUMANS; HYDROCORTISONE; HYPERTENSION; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 0038457940     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000070024.59313.AE     Document Type: Article

References (20)

1. Whitworth J, Mangos G, Kelly J. Cushing, cortisol, and cardiovascular disease. Hypertension. 2000;36:912-916.
2. Pirpiris M, Yeung S, Dewar E, Jennings GL, Whitworth JA. Hydrocortisone-induced hypertension in men: THE role of cardiac output. Am J Hypertens. 1993;6:287-294.
3. Tam SH, Williamson PM, Kelly JJ, Whitworth JA. Autonomic blockade amplifies cortisol-induced hypertension in man. Clin Exp Pharmacol Physiol. 1997;24:31-33.
4. Turner SW, Wen C, Lim A, Whitworth JA. L-Arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension. 1996;27:184-189.
5. Kelly JJ, Tam SH, Williamson PM, Lawson J, Whitworth JA. The nitric oxide system and cortisol-induced hypertension in humans. Clin Exp Pharmacol Physiol. 1998;25:945-946.
6. Mangos GJ, Walker BR, Kelly JJ, Lawson JA, Webb DJ, Whitworth JA. Cortisol inhibits cholinergic vasodilatation in the human forearm. Am J Hypertens. 2000;13:1155-1160.
7. Kaye DM, Ahlers BA, Auelitano DJ, Chin-Dusting JP. In vivo and in vitro evidence for impaired arginine transport in human heart failure. Circulation. 2000;102:2707-2712.
8. Bruning TA, Kemme MJ, Chang PC, Muizert Y, van Zwieten PA. Calculation of plasma concentration of intra-arterially infused compounds in forearm plethysmography. Cardiovasc Res. 1998;37:210-215.
9. Wallerath T, Witte K, Schater SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, Fostermann U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA. 1999;96:13357-13362.
10. Lou Y, Kiwen E, Li M, Adams DJ, Wong MX, Yang F, Morris BJ, Whitworth JA. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension. Hypertension. 2001;37:1164-1170.
11. Johns DG, Dorrance AM, Tramontini NL, Webb RC. Glucocorticoids inhibit tetrahydrobiopterin-dependent endothelial function. Exp Biol Med. 2001;226:27-31.
12. Kelly J, Williamson P, Martin A, Whitworth JA. Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol-treated humans. J Hypertens. 2001;19:263-268.
13. Whitworth J, Saines D, Scoggins B. Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man. Clin Exp Hypertens. 1984;6:795-809.
14. Williamson P, Kelly J, Whitworth J. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J Hypertens. 1996;14:S37-S41.
15. Closs E. CATs, a family of three distinct mammalian cationic amino acid transporters. Amino Acids. 1996;11:193-208.
16. Pollock J, Forstermann U, Mitchell J. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA. 1991;88:10480-10484.
17. Laurant P, Demolombe B, Berthelot B. Dietary L-arginine attenuates blood pressure in mineralocorticoid-salt hypertensive rats. Clin Exp Hypertens. 1995;17:1009-1024.
18. He H, Kimura S, Fujisawa Y, Tomohiro A, Kiyomoto K, Aki Y, Abe Y. Dietary L-arginine supplementation normalizes regional blood flow in Dahl-Iwai salt-sensitive rats. Am J Hypertens. 1997;10:89S-93S.
19. Wen C, Li M, Fraser T, Wong J, Turner SW, Whitworth JA. L-Arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Press. 2000;9:298-304.
20. Kaye DM, Parnell MM, Ahlers BA. Reduced myocardial and systemic L-arginine uptake in heart failure. Circ Res. 2002;91:1198-1203.